Which kidney donor is better a mother aged 75 years with same blood group or wife with different blood group ?

Reading File
Searching PubMed

living kidney donor age outcomes graft survival

Searching PubMed

ABO incompatible kidney transplant outcomes desensitization

Finding Sources
Finding Sources
Reading Article

PMID: 35072936

Reading Article

PMID: 41782862

Reading File
Reading File
Reading File
I now have comprehensive data from authoritative textbooks and recent meta-analyses. Here is a thorough answer:

Kidney Donor Comparison: 75-Year-Old Mother (Same Blood Group) vs. Wife (Different Blood Group)

Bottom Line

The wife with a different blood group is the better donor, provided she is younger (presumably 30s-50s), medically fit, and willing to undergo desensitization. Age of the donor is a more powerful predictor of long-term graft survival than ABO compatibility, and ABO incompatibility is now a manageable (though not trivial) barrier.

1. Why Donor Age Matters So Much

From Brenner and Rector's The Kidney:
"Older kidney donor age is associated with reduced kidney transplant survival. A donor age effect is apparent among deceased and living donor transplants. These results are thought to reflect a higher incidence of delayed graft function (DGF) and of nephron 'underdosing.' Allografts from older donors have fewer functioning nephrons because of the aging process and donor-related conditions such as hypertension and atherosclerosis."
  • Graft survival was significantly higher in recipients of kidneys from donors aged <60 vs. >60.
  • Risk of acute rejection was lower (RR 0.62, 95% CI 0.5-0.8) with younger donors.
  • Risk of delayed graft function was dramatically lower (RR 0.28, 95% CI 0.1-0.9) with younger donors.
  • 1-year serum creatinine was significantly lower with donors <60 years.
A 75-year-old donor is well above the critical threshold. Most US transplant centers cap living donors at 65 years. While the National Kidney Foundation Primer notes that some older living donors (>55 years) can achieve graft survival rivaling younger deceased donors, a 75-year-old represents an extreme. At 75:
  • GFR declines at ~9 mL/min/1.73 m² per decade after age 40
  • The donated kidney starts with a reduced nephron reserve
  • Risk of DGF, faster progression of chronic allograft nephropathy, and shorter graft longevity are all substantially elevated

2. ABO Incompatibility - A Manageable Barrier

From Brenner and Rector's The Kidney:
"ABO-incompatible protocols now mostly entail a relatively short but intensive pretransplant regimen consisting of rituximab, IVIg, and plasmapheresis - continued until anti-A/B titers fall below a prespecified safe threshold (usually 1:8 or 1:16)... The long-term outcome of desensitized recipients of blood group incompatible organs is good although perhaps slightly inferior to that of ABO-compatible kidney transplant recipients, much of the excess risk being concentrated in the early post-transplant period."
A 2026 meta-analysis (Chen et al., PMID 41782862) pooling 18 studies and 15,611 recipients found:
  • Short- to mid-term patient and graft survival in ABO-incompatible living donor kidney transplant (ABOi-LDKT) was comparable to ABO-compatible transplants in modern cohorts with desensitization.
  • No significant difference in DGF, acute rejection, or surgical complications.
  • Main downside: higher hospitalization costs due to desensitization procedures.

3. Head-to-Head Comparison

Factor75-yr Mother (ABO compatible)Younger Wife (ABO incompatible)
Blood group barrierNoneRequires desensitization (rituximab + plasmapheresis + IVIg)
Donor nephron reserveSignificantly reducedWell-preserved (age-dependent)
Risk of delayed graft functionHighLow
Expected graft half-lifeShorter (nephron underdosing + aging)Longer
Acute rejection riskLower (compatible match)Slightly higher early post-transplant
Donor surgical riskHigher (age-related perioperative risk)Lower
Long-term graft survivalInferiorSuperior
Cost/complexityStandard protocolMore complex and costly
Alternative: paired exchange?Could keep mother as backupWife may not need desensitization if paired exchange possible

4. Practical Considerations

  1. Paired/Chain Exchange Programs: Before desensitizing, check if the wife can enter a kidney paired exchange program - she donates to a compatible recipient, and the patient gets a compatible kidney from another donor. This avoids desensitization entirely and may yield an even better-matched organ.
  2. Anti-A/B Titer of Wife: If the recipient's anti-A/B titer is already low (e.g., A2 blood group donor into a B recipient), desensitization may be minimal or unnecessary.
  3. HLA Matching: The mother, being a first-degree relative, may have better HLA matching. The wife may have no HLA sharing. However, with modern immunosuppression, HLA mismatch is much less impactful than donor age on outcomes.
  4. Mother's Candidacy at 75: Most international guidelines and centers would carefully scrutinize or decline a 75-year-old donor due to reduced functional reserve. The donor evaluation (GFR, cardiovascular status, proteinuria, imaging) would need to be thorough.
  5. KDIGO 2017 Living Donor Guidelines recommend against advanced-age donors with significant comorbidities, and a 75-year-old is at minimum a high-risk donor.

Summary

Choose the wife (ABO-incompatible but younger) - unless she has significant health issues of her own. A younger, healthy kidney with a manageable immunological barrier far outperforms an aged kidney from an otherwise "compatible" source. Donor age at 75 years is a substantial biological disadvantage that no degree of blood group compatibility can fully overcome. The ABO barrier, by contrast, is now routinely crossed with modern desensitization protocols with acceptable outcomes.
Sources: Brenner and Rector's The Kidney, p. 2977-2997; NKF Primer on Kidney Diseases 8e, p. 566-571; Bellini MI et al., J Nephrol 2022 [PMID 35072936]; Chen Y et al., Front Immunol 2026 [PMID 41782862]
This is a shared conversation. Sign in to Orris to start your own chat.